These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10665491)

  • 1. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
    Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
    Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Parkinson's disease.
    Polymeropoulos MH
    Ann N Y Acad Sci; 2000; 920():28-32. PubMed ID: 11193165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular pathogenesis of familial Parkinson's disease].
    Kitada T; Mizuno Y
    Nihon Rinsho; 2000 Oct; 58(10):2016-21. PubMed ID: 11068440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex interactions in Parkinson's disease: a two-phased approach.
    Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
    J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.
    Lim KL; Dawson VL; Dawson TM
    Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
    Lansbury PT; Brice A
    Curr Opin Genet Dev; 2002 Jun; 12(3):299-306. PubMed ID: 12076673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological proteins in Parkinson's disease: focus on the proteasome.
    Snyder H; Wolozin B
    J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of alpha-synuclein, parkin, tau, and UCH-L1 in a Japanese family with autosomal dominant parkinsonism.
    Hasegawa K; Funayama M; Matsuura N; Furusawa H; Sakai F; Kowa H; Obata F
    Eur Neurol; 2001; 46(1):20-4. PubMed ID: 11455179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
    Liu Y; Fallon L; Lashuel HA; Liu Z; Lansbury PT
    Cell; 2002 Oct; 111(2):209-18. PubMed ID: 12408865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
    Lansbury PT; Brice A
    Curr Opin Cell Biol; 2002 Oct; 14(5):653-60. PubMed ID: 12231362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Parkinson's disease.
    Gasser T
    J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage exclusion in French families with probable Parkinson' s disease.
    Farrer M; Destée T; Becquet E; Wavrant-De Vrièze F; Mouroux V; Richard F; Defebvre L; Lincoln S; Hardy J; Amouyel P; Chartier-Harlin MC
    Mov Disord; 2000 Nov; 15(6):1075-83. PubMed ID: 11104189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
    Goldberg MS; Lansbury PT
    Nat Cell Biol; 2000 Jul; 2(7):E115-9. PubMed ID: 10878819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.